Literature DB >> 16437682

Response of porcine hepatocytes in primary culture to plasma from severe viral hepatitis patients.

Yong-Bo Cheng1, Ying-Jie Wang, Shi-Chang Zhang, Jun Liu, Zhi Chen, Jia-Jia Li.   

Abstract

AIM: To observe the effects of plasma from patients with severe viral hepatitis (SVHP) on the growth and metabolism of porcine hepatocytes and the clinical efficiency of bioartificial liver device.
METHODS: Hepatocytes were isolated from male porcines by collagenase perfusion. The synthesis of DNA and total protein, leakages of AST and LDH, changes in glutathione (GSH), catalase and morphology of porcine hepatocytes exposed to SVHP were investigated to indicate the effect of plasma from patients with severe hepatitis on the growth, injury, detoxification, and morphology of porcine hepatocytes.
RESULTS: The synthesis of DNA and protein was inhibited in the medium containing 100% SVHP compared to the controls. The leakages of LDH and AST increased in porcine hepatocytes following exposure to 100% SVHP for 5 h. The difference between 100% SVHP and 10% newborn calf serum (NCS) was significant in t-test (LDH: t = 24.552, P = 0.001; AST: t = 4.169, P = 0.014). After exposure to SVHP for 24 h, alterations in GSH status were significant (F = 2.746, P<0.05) between porcine hepatocytes in 100% SVHP and 10% NCS, but no alteration occurred in the culture medium after 48 h (F = 4.378, P<0.05). A similar profile was observed in catalase activity. Many round vacuoles were observed in porcine hepatocytes cultured in SVHP. The membranes of these cells became indistinct and almost all the cells died on d 5.
CONCLUSION: Plasma from patients with severe hepatitis inhibits the growth, injures membrane, disturbs GSH homeostasis and induces morphological changes of porcine hepatocytes. It is suggested that SVHP should be pretreated to reduce the toxin load and improve the performance of porcine hepatocytes in extracorporeal liver-support devices.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437682      PMCID: PMC4727237          DOI: 10.3748/wjg.v11.i48.7585

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Experience with a porcine hepatocyte-based bioartificial liver support system.

Authors:  D C Mears; G Stewart; J Sun; K Woodman; R Bourne; L Wang; A G R Sheil
Journal:  Transplant Proc       Date:  2003-02       Impact factor: 1.066

2.  Cryopreservation of suckling pig hepatocytes.

Authors:  Z Chen; Y Ding; H Zhang
Journal:  Ann Clin Lab Sci       Date:  2001-10       Impact factor: 1.256

3.  Requirements for induction of DNA strand breaks by lithocholic acid.

Authors:  M S Kulkarni; B A Cox; K L Yielding
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

4.  Cytotoxicity of bile in human Hep G2 cells and in primary cultures of rat hepatocytes.

Authors:  A D Smirthwaite; J D Gaylor; R B Cousins; M H Grant
Journal:  Artif Organs       Date:  1998-10       Impact factor: 3.094

5.  Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes.

Authors:  D M Heuman; W M Pandak; P B Hylemon; Z R Vlahcevic
Journal:  Hepatology       Date:  1991-11       Impact factor: 17.425

6.  The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells.

Authors:  Q Shi; J D Gaylor; R Cousins; J Plevris; P C Hayes; M H Grant
Journal:  Artif Organs       Date:  1998-12       Impact factor: 3.094

7.  The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.

Authors:  R D Hughes; A M Cochrane; A D Thomson; I M Murray-Lyon; R Williams
Journal:  Br J Exp Pathol       Date:  1976-06

8.  Characterization of the effects induced on DNA in mouse and hamster cells by lithocholic acid.

Authors:  P Russo; M Taningher; M Pala; V Pisano; P Pedemonte; M T De Angeli; S Carlone; L Santi; S Parodi
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

9.  Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content.

Authors:  T Ohiwa; K Katagiri; M Hoshino; T Hayakawa; T Nakai
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

10.  Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta, in the rat model of fulminant hepatic failure.

Authors:  Eiji Nozato; Masayuki Shiraishi; Tadashi Nishimaki
Journal:  J Surg Res       Date:  2003-12       Impact factor: 2.192

View more
  3 in total

Review 1.  Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.

Authors:  Huidong Zhou; Hong Liu; Mohamed Ezzelarab; Eva Schmelzer; Yi Wang; Jörg Gerlach; Bruno Gridelli; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-05-07       Impact factor: 3.907

2.  Integration of single-layer skin hollow fibers and scaffolds develops a three-dimensional hybrid bioreactor for bioartificial livers.

Authors:  Shichang Zhang; Li Chen; Tao Liu; Zhengguo Wang; Yingjie Wang
Journal:  J Mater Sci Mater Med       Date:  2013-08-21       Impact factor: 3.896

3.  Artificial liver research output and citations from 2004 to 2017: a bibliometric analysis.

Authors:  Yan Li; Meizhi He; Ziyuan Zou; Xiaohui Bian; Xiaowen Huang; Chen Yang; Shuyi Wei; Shixue Dai
Journal:  PeerJ       Date:  2019-01-11       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.